CGS-authored

California's stem cell institute yesterday unveiled its plans for spending $3 billion in a 149-page, no-hype document that sets what experts and patient advocates described as conservative and attainable goals.

Not one stem cell therapy is expected to be approved for market within the next 10 years of state-funded stem cell research under the proposal. But the plan would allocate funding for jump-starting embryonic stem cell research and the creation of a statewide embryo bank.

More than $1.6 billion would be directed toward scientific research, with the rest going toward facilities, infrastructure, training and public outreach.

In the first few years, the institute would make millions of dollars available for studying tissue engineering, the auto-immune system and the development of human eggs and embryos. Later, after basic scientific discoveries are made, there would be $451 million with which research institutes and private industry could begin early-stage clinical trials on animals and humans.

_We didn't set out consciously to be cautious, but we did want to set goals that we think we can achieve with some luck,_ said Zach Hall, president...